Accessibility Menu
 
Hemagen Diagnostics logo

Hemagen Diagnostics

(OTC) HMGN

Current Price$0.00
Market Cap$3,100
Since IPO (1993)-100%
5 Year-100%
1 Year+19,900%
1 Month+100%

Hemagen Diagnostics Financials at a Glance

Market Cap

$3,100

Revenue (TTM)

$4.04M

Net Income (TTM)

$907.32K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-21.52 (Low)

Price

$0.00

Volume

50

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

HMGN News

No articles available.

HMGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hemagen Diagnostics

Industry

Healthcare Equipment and Supplies

Headquarters

Columbia, MD 21045, US

HMGN Financials

Key Financial Metrics (TTM)

Gross Margin

40%

Operating Margin

-11%

Net Income Margin

-22%

Return on Equity

0%

Return on Capital

-89%

Return on Assets

-37%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.10K

Shares Outstanding

15.50M

Volume

50

Short Interest

0.00%

Avg. Volume

385.443

Financials (TTM)

Gross Profit

$1.61M

Operating Income

$437.91K

EBITDA

$273.89K

Operating Cash Flow

$358.69K

Capital Expenditure

$91.04K

Free Cash Flow

$449.72K

Cash & ST Invst.

$66.29K

Total Debt

$5.03M

Hemagen Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2012YOY CHG

Revenue

$875.91K

-23.6%

Gross Profit

$402.13K

-14.1%

Gross Margin

45.91%

N/A

Market Cap

$3.10K

N/A

Market Cap/Employee

$206.67

N/A

Employees

15

N/A

Net Income

$162.98K

+42.2%

EBITDA

$6.03K

+95.2%

Quarterly Fundamentals

Name
Q4 2012YOY CHG

Net Cash

$4.96M

-10.1%

Accounts Receivable

$587.52K

-4.5%

Inventory

$1.36M

-6.7%

Long Term Debt

$4.05M

+0.0%

Short Term Debt

$976.87K

+45.9%

Return on Assets

-37.14%

N/A

Return on Invested Capital

-88.82%

N/A

Free Cash Flow

$54.40K

-213.4%

Operating Cash Flow

$50.84K

-178.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RGRXRegeneRx Biopharmaceuticals, Inc.
$0.00+0.00%
DRWNQuantum Medical Transport, Inc.
$0.00+0.00%
NBIONascent Biotech, Inc.
$0.00+0.00%
FFNTF4Front Ventures Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About HMGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.